Your browser doesn't support javascript.
loading
Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study.
Launspach, Michael; Temel, Dennis; Ohlendorf, Emily; Zirngibl, Felix; Materne, Bianca; Oevermann, Lena; Deubzer, Hedwig E; Henssen, Anton G; Künkele, Annette; Hundsdörfer, Patrick; Bernuth, Horst von; Pruß, Axel; Eggert, Angelika; Stackelberg, Arend von; Lang, Peter; Schulte, Johannes H.
Afiliación
  • Launspach M; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; The German Cancer Research Center (DKFZ), He
  • Temel D; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin.
  • Ohlendorf E; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin.
  • Zirngibl F; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin.
  • Materne B; Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin.
  • Oevermann L; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin.
  • Deubzer HE; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; The German Cancer Research Center (DKFZ), He
  • Henssen AG; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; The German Cancer Research Center (DKFZ), He
  • Künkele A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; The German Cancer Research Center (DKFZ), He
  • Hundsdörfer P; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Pediatrics, Helios Klinikum Berlin-Buch, Berlin.
  • Bernuth HV; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany; Deparment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; Labor Berlin - Charité Vivantes GmbH, Department of Immunology, Berlin, Germany; Ber
  • Pruß A; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin.
  • Eggert A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; The German Cancer Research Center (DKFZ), He
  • Stackelberg AV; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin.
  • Lang P; Department of Hematology/Oncology and General Pediatrics, Children's University Hospital, University of Tuebingen, Tuebingen.
  • Schulte JH; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany; The German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; The German Cancer Research Center (DKFZ), He
Haematologica ; 108(1): 267-272, 2023 01 01.
Article en En | MEDLINE | ID: mdl-36134454
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article